UPC CFI 430/2023

At the UPC: Abbott Group (67 cases)·Dexcom Group (39 cases)

• 2025-01-20
  Application RoP 265Public

  Summary: The Nordic-Baltic Regional Division declared proceedings closed following the mutual withdrawal of Abbott Diabetes Care Inc.'s infringement action and Dexcom's counterclaim for revocation concerning EP 3 977 921. Both parties consented to each other's withdrawal and agreed that no cost decision would be issued.

  Show the legal issues (3)

  • Withdrawal of infringement action and counterclaim for revocation (R. 265 RoP)
  • Mutual consent
  • No costs decision
• 2024-10-07
  Public

  Summary: Nordic-Baltic Regional Division (judge-rapporteur Kai Härmand) preliminary/case management order in Abbott Diabetes Care Inc.'s infringement action against Dexcom Inc. and Dexcom International Limited concerning EP 3 977 921 (a continuous glucose monitoring patent). The order addresses multiple pending applications including Abbott's R. 190 application to communicate information (partially dismissed following Paris LD precedent), Abbott's R. 191 application (found admissible but not justified), Abbott's application to change the statement of claim, Dexcom's request for security for legal costs, and sets procedural deadlines and oral hearing preparation steps.

  Show the legal issues (6)

  • Application to communicate information (R. 191 RoP / Art. 67 UPCA) – admissible but not justified
  • R. 190 RoP evidence order
  • Amendment of statement of claim
  • Security for legal costs
  • Pending EPO opposition proceedings
  • Procedural deadlines and oral hearing preparation